| Endocrinology and Metabolism amanda.berberich@sjhc.london.on.ca |
|||
 AMANDA BERBERICH, MD, FRCPC, Assistant Professor Bio Sketch and keywords unavailable. Keywords: Genetics Heritable Endocrine Disorders Lipids Monogenic Diabetes | |||
| Endocrinology and Metabolism Kristin.Clemens@sjhc.london.on.ca |
|||
 KRISTIN CLEMENS, MD, MSC, FRCPC, Associate ProfessorDr. Kristin Clemens is a Clinician-Scientist and Endocrinologist at St. Joseph’s Health Care London, Senior Adjunct ICES Scientist, Associate Professor of Medicine (Endocrinology) and Epidemiology & Biostatistics at Western University, Associate Scientist at Lawson Health Research Institute, and Medical Director of the Osteoporosis and Bone Disease Program at St. Joseph’s Health Care London. She also holds the Diabetes Canada Chair in Diabetes Management at the Schulich School of Medicine & Dentistry. Dr. Clemens’ research program is dedicated to improving care and outcomes for patients with complex endocrine and metabolic disorders. She has special interest in diabetes, cardiovascular-kidney-metabolic syndrome (CKM) and metabolic bone disease. Her work integrates population-based data science, patient-oriented research, innovative randomized controlled trials, qualitative methodologies, and quality improvement initiatives to address critical gaps in clinical care and health system delivery. She currently leads more than 10 research programs and oversees 18 active research projects focused on diabetes and CKM, obesity management in kidney transplantation, osteoporosis and chronic kidney disease cardiovascular screening gaps in women, and medication effectiveness and safety. She has helped to create system-level innovations for people with endocrine diseases with stakeholders including BestCare eConsult and GeriMedRisk. Her research has been supported by major national funding bodies including the Canadian Institutes of Health Research, the Kidney Foundation of Canada, Diabetes Canada, AMOSO, and the Schulich School of Medicine & Dentistry. With over 10 years of experience in research mentorship, Dr. Clemens has supervised and mentored approximately 60 undergraduate, graduate, and postgraduate trainees to date. She has authored more than 90 peer-reviewed publications. Dr. Clemens is the recipient of the Department of Medicine’s Award of Excellence in Quality Improvement and the Department of Medicine Award of Excellence in Research, recognizing her leadership in advancing clinical care and academic innovation. She also received the Dean’s Award for Research Excellence (Early Career) from the Schulich School of Medicine. PubMed: Kristin K Clemens Keywords: Cardiovascular-Kidney-Metabolic Syndrome Chronic Kidney Disease (CKD) Diabetes Drug efficacy Drug safety Endocrinology Health Services Research Metabolic Disorders Quality Improvement Randomized Controlled Trials Women’s Health | |||
| Endocrinology and Metabolism hegele@robarts.ca |
|||
 ROBERT HEGELE, MD, FRCPC, FACP, FAHA, FCAHS, Distinguished University ProfessorRob Hegele cares for >2800 clinic patients at University Hospital in London, Ontario. He has published >1000 papers with >100,000 citations and is among Clarivate’s top 0.1% of highly cited scientists. His laboratory discovered the causal genetics for >15 diseases and invented a DNA diagnostic panel for dyslipidemia now routinely used in Ontario. He was among the first in the world to use five medications that are now routinely prescribed. He received the 2019 American Heart Association Lyman Duff Award and the 2020 US FH Foundation Pioneer Award. In 2025 has was inducted into the Canadian Medical Hall of Fame and the Royal Society of Canada. He has co-authored many clinical practice guidelines and has trained numerous physicians and medical students. Keywords: Association/linkage analysis Atherosclerosis Bioinformatic analysis Cloning Coronary heart disease DNA sequencing Dyslipidemia Genetics Insulin resistance Lipids/lipoproteins Metabolic syndrome Metabolism MRI Mutation identification Next generation sequencing Obesity PCR Type 2 diabetes Whole exome sequencing Whole genome sequencing | |||
| Endocrinology and Metabolism tjoy@uwo.ca |
|||
 TISHA JOY, MD, FRCPC, Associate ProfessorDr. Joy received her medical degree from the Western University, Canada in 2001. After completing residency training at Western University in 2006, she went on to be a research fellow specializing in HIV lipodystrophy at Massachusetts General Hospital (Harvard Medical School) in Boston, MA. Upon completion of this in 2007, she pursued another research fellowship in genetic lipodystrophies and dyslipidemia at Robarts Research Institute, London, ON, until 2008. She is an Associate Professor in the Division of Endocrinology and Metabolism at Western University and Associate Scientist in the Lawson Health Research Institute. Her research interests include type 2 diabetes, obesity, and lipid disorders, including statin-associated muscle symptoms and has published several articles in these areas. She has been invited as a guest speaker for the Meet the Professor/Meet the Expert sessions at the American Heart Association and Endocrine Society conferences. She also has collaborated on research initiatives related to equity, diversity, and inclusion. She has a Diversity and Inclusion Certificate from Cornell in 2021, and is the Equity, Diversity, Inclusion and Belonging Lead for the Department of Medicine (2023 to present). Keywords: Body fat distribution Equity, diversity, and inclusion Lipid disorders Obesity Statin myopathy statin-associated muscle symptoms Type 2 diabetes | |||
| Endocrinology and Metabolism sliu@uwo.ca |
|||
 SELINA LIU, MD, MSc, FRCPC Cert Endo, Associate ProfessorDr. Selina Liu is an Associate Professor in the Division of Endocrinology & Metabolism, Department of Medicine, Schulich School of Medicine & Dentistry, Western University. She is also cross-appointed to the Department of Obstetrics & Gynaecology and is an Associate Scientist at Lawson Health Research Institute. Dr. Liu obtained her medical degree at Queen’s University, Kingston (2006), completed her Internal Medicine residency (2010) and Endocrinology & Metabolism fellowship (2011) at Western University. She was the recipient of the 2011 Schulich Resident Research Career Development program award which supported her Master’s degree in Clinical Epidemiology (2014). She also had previously completed a Master’s degree in Pharmacology & Toxicology (2004) prior to her medical training. Dr. Liu joined the Division of Endocrinology & Metabolism, Department of Medicine as a Clinician-Researcher in 2014. She is the Medical Director of the St. Joseph’s Healthcare London Endocrine Pregnancy Clinic, which is the regional referral centre for endocrine problems in pregnancy. She has participated as Site Principal Investigator for both investigator-initiated and pharma-sponsored multi-centre clinical trials of new insulins and glucose monitoring systems for diabetes in pregnancy, and of new medications for type 2 diabetes. Other research interests include strategies to improve diabetic retinopathy screening and treatment. Keywords: Clinical trials Diabetic retinopathy screening Endocrine problems in pregnancy | |||
| Endocrinology and Metabolism tspaic@uwo.ca |
|||
 TAMARA SPAIC, MD, FRCPC, Associate ProfessorDr. Tamara Spaic is an Associate Professor in the Department of Medicine, Division of Endocrinology and Metabolism at the University of Western Ontario (Western). She trained in internal medicine and endocrinology at Western University. She completed a two-year research fellowship at Western University where she also received her Master of Science degree in clinical epidemiology and biostatistics. Dr Spaic has a clinical practice in adult endocrinology with a focus on type 1 diabetes. She is working with the National Diabetes Management Strategy Team on improving the quality of care for people with diabetes in Canada. Dr Spaic’s research interest is in improving health outcomes of individuals with type 1 diabetes and closing the care gap between pediatric and adult care. She is a co-Principal Investigator of the Transition Trial assessing structured transition from pediatric to adult care in adolescents and young adults with type 1 diabetes. She also participates in various other multicenter trials involving type 1 diabetes patients. Further, her interest is in the use of electronic medical records and clinical databases in diabetes research. Keywords: Electronic medical records Transition Type 1 diabetes | |||
| Endocrinology and Metabolism stan.vanuum@sjhc.london.on.ca |
|||
 STANISLAUS VAN UUM, MD, PhD, FRCPC, Professor
Dr. Stan Van Uum is an Associate Professor in the divisions of Endocrinology & Metabolism and Clinical Pharmacology, Western University, London, Ontario. He completed his undergraduate and graduate training in Internal Medicine in 1997, followed by a Fellowship in Endocrinology and Metabolism (2001), all at the University of Nijmegen in The Netherlands. He then completed his PhD in Medicine on the role of cortisol metabolism in hypertension. Dr. Van Uum is interested in the role of hormones, particularly steroid hormones, in health and disease. These studies include consequences of drug-induced hypogonadism, and the measurement of steroid hormones in hair. His research group now is a global leader in the measurement of steroid hormones in hair. Other studies focus on thyroid cancer and thyroid hormone treatment. His clinical practice is focused on endocrinology, with a particular interest in pituitary, thyroid and adrenal diseases, and secondary hypertension. He is cofounder of the multidisciplinary pituitary team in London, Ontario. Stan Van Uum is actively involved in teaching in relation to these areas, and Program Director for Endocrinology and Metabolism. Keywords: Adrenal Cortisol Hair Pituitary Thyroid cancer | |||
